期刊文献+

卡泊芬净、米卡芬净对8种皮肤癣菌体外抑菌活性的研究 被引量:5

In vitro antifungal activity of caspofungin and micafungin against 8 species of dermatophyte
下载PDF
导出
摘要 目的评价棘白菌素类抗真菌药物卡泊芬净(caspofungin)、米卡芬净(micafungin)针对常见致病性皮肤癣菌的体外抗菌活性。方法参考CLSI制定的M38-A2方案。测定82株常见皮肤癣菌的最低有效浓度(minimal effective concentrations,MECs)。结果按照MEC90浓度从高到低,米卡芬净对紫色毛癣菌和断发毛癣菌的MEC90是0.25μg/mL;对犬小孢子菌、疣状毛癣菌的MEC90为0.06μg/mL;对红色毛癣菌、须癣毛癣菌、石膏小孢子菌、絮状表皮癣菌的MEC90均在0.03μg/mL。②卡泊芬净对红色毛癣菌、紫色毛癣菌和断发毛癣菌的MEC90为1μg/mL;对须癣毛癣菌、犬小孢子菌、石膏小孢子菌、絮状表皮癣菌和疣状毛癣菌的MEC90为0.5μg/mL。③根据中位数检验,米卡芬净对几种皮肤癣菌的MEC值均低于卡泊芬净的MEC值,统计学比较有显著性差异(P<0.05)。结论米卡芬净和卡泊芬净对皮肤癣菌有较强的抑菌作用,米卡芬净的MEC值低于卡泊芬净。 Objective To investigate the in vitro antifungal activity of two new echinocandin antifungal drugs, micafungin and caspofungin, against dermatophyte. Methods Minimal effective concentrations (MECs) of micafungin and caspofungin to 82 dermatophyte strains were tested according to CLSI (Clinical and laboratory Standards Institute, formerly NCCLS) M38-A2 broth microdilution methods. Results ①From high to low, the MEC90s of Micafungin for T. violaceum and T. tonsurans were 0. 25 μg/mL,followed by those for M. canis and T. verrucous with the MEC90s of 0.06 μg/mL. The MEC90s for T. rubrum,T, mentagrophytes,M. gypseum and E.floccosum were 0.03 μg/mL. ②The MEC90s of Caspofungin for T. rubrum, T. violaceum and T. tonsurans were 1 μg/ mL, followed by those for T. mentagrophytes ,M. canis ,M. gypseum,E.floccosum and T. verrucous with the MEC90s of 0.5μg/mL. ③ Micafungin exhibited more effective antifungal activity to dermatophytes than caspofungin statistically ( P 〈 0.05 respectively). Conclusion Micafungin showed stronger antifungal activity than caspofungin with lower MEC.
出处 《中国真菌学杂志》 2009年第2期73-77,107,共6页 Chinese Journal of Mycology
关键词 皮肤癣菌 抗真菌药物敏感性试验 体外 卡泊芬净 米卡芬净 dermatophyte antifungal susceptibility testing, in vitro caspofungin micafungin
  • 相关文献

参考文献5

二级参考文献110

  • 1Julia Lynch,Annie Wong-Beringer,席瑜钦.卡泊芬净引起严重可逆性血小板减少[J].中国处方药,2005,4(2):75-77. 被引量:4
  • 2陈端,单斌,骈淮燕,杜艳,郭翀.医院真菌感染1225例分析[J].中华检验医学杂志,2005,28(4):387-388. 被引量:44
  • 3李若瑜,刘伟,乔建军.烟曲霉对唑类抗真菌药物耐药的分子机制研究现况[J].中国处方药,2006,5(3):38-41. 被引量:4
  • 4David W D. Echinocandin antifungal drugs[J]. Lancet, 2003, 362(9390):1142-1151.
  • 5Black R M, Balkovec J M, Nollstadt K M, et al. Synthesis and structure-activity relationships of novel 3′-hty-substituted pneumocandins[J]. Bioorg & Med Chem Lett, 1997,7(22):2879-2884.
  • 6Balkovec J M, Bouffard F A, Black R M. Aza cyclohexa-peptide compounds[P]. WO:9421677,1994-09-29.
  • 7Masaki Tomishima, Hidenori Ohki, Akira Yamada, et al. FK463, a novel water-soluble echinocandin lipopeptide:synthesis antifungal activity[J]. J Antibiot, 1999,52(7):674-676.
  • 8Boucher H W, Groll A H, Chiou C C, et al. Newer systemic antifungal agents[J]. Drugs, 2004, 64(18):1997-2020.
  • 9Lilly. Antifungal[J]. Drugs Fut,1996,21(4):441-442.
  • 10Chen S H, Rodriguez M. Antifungal lipopeptides: a tale of Pseudomycin prodrugs and analogues[J]. Drugs Fut, 2003,28(5):441-463.

共引文献64

同被引文献55

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部